CIDP patients switching to HyQvia: what drives the choice?
NCT ID NCT06538064
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 30 adults with chronic inflammatory demyelinating polyneuropathy (CIDP) who are switching to the treatment HyQvia. Researchers will use questionnaires and medical records to understand why patients chose to switch, how satisfied they are, and how the treatment affects their symptoms, daily life, and work. The goal is to gather real-world information on the use and outcomes of HyQvia in routine medical care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (CIDP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Arhus Universtitetshospital
RECRUITINGAarhus N, 8200, Denmark
-
HSHS St. Elizabeths Hospital
RECRUITINGO'Fallon, Illinois, 62269, United States
-
Hawaii Pacific Neuroscience
RECRUITINGHonolulu, Hawaii, 96817, United States
-
Immanuel Klinik Rudersdorf
RECRUITINGRüdersdorf, Brandenburg, 15562, Germany
-
Judisches Krankenhaus Berlin
NOT_YET_RECRUITINGBerlin, 13347, Germany
-
Katholisches Klinikum Bochum gGmbH
RECRUITINGBochum, North Rhine-Westphalia, 44791, Germany
-
Neuro/Psych Sleep Clinic
RECRUITINGSan Francisco, California, 94143, United States
-
Nova Clinical Research, LLC
RECRUITINGBradenton, Florida, 34209, United States
-
Rigshospitalet
RECRUITINGKøbenhavn Ø, 2100, Denmark
-
Samir Macwan MD Inc
RECRUITINGRancho Mirage, California, 92270, United States
-
Suncoast Neuroscience Associates, Inc.
NOT_YET_RECRUITINGSt. Petersburg, Florida, 33713, United States
-
Universitaetsklinikum Giessen und Marburg GmbH Standort Marburg
NOT_YET_RECRUITINGMarburg, Hesse, 35043, Germany
-
University of Kansas Medical Center Research Institute, Inc.
RECRUITINGKansas City, Kansas, 66160, United States
-
Wake Forest University - School of Medicine - Central
RECRUITINGWinston-Salem, North Carolina, 27157, United States
-
Yale School Of Medicine
NOT_YET_RECRUITINGNew Haven, Connecticut, 06510, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental drug aims to tame rare nerve disorder
- New hope for teens with rare nerve disease: drug trial launches
- New hope for CIDP: modified immune protein enters human testing
- New immune globulin drug shows promise for rare nerve diseases in japan
- New shot for nerve disease could mean fewer infusions